# EVEROLIMUS
> **ANDA219955** · Abbreviated New Drug Application (Generic) · Sponsor: NOVUGEN · Approved 2025-10-30
## Drug
- **FDA Application Number:** ANDA219955
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EVEROLIMUS
- **Generic name:** EVEROLIMUS
- **Active ingredients:** EVEROLIMUS
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVUGEN
- **Manufacturer:** Novugen Pharma (USA) LLC.
- **First approval:** 2025-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219955)
---
*AI Analytics · CC0 1.0*